Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001104659-18-038398

Options or other derivatives

  • Director acquired 17,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
POTTER MYRTLE S Director 2018-06-01 Grant or award · Stock Options (right to buy) +13,000 13,000 D: show line 1 in the form
POTTER MYRTLE S Director 2018-06-01 Grant or award · Stock Options (right to buy) +4,000 4,000 D: show line 2 in the form
Loading xslF345X03/a4.xml…